A mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma compared with other variants, according to a multicenter study conducted at Weill Cornell Medicine, NewYork-Presbyterian and other institutions.
A new study emphasizes the importance of considering sex differences in Alzheimer’s research – a step that could ultimately lead to more precise and effective treatments.
A multidisciplinary team aims to build a more inclusive AI shaped by global cultures and knowledge – one of three projects that make up Cornell’s new GlobalGrand Challenge: The Future.
A powerful new analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable, as shown in a study from researchers at Weill Cornell Medicine and the New York Genome Center.
Faculty and staff within Cornell’s Department of Public & Ecosystem Health have been funded by the U.S. Centers for Disease Control and Prevention’s (CDC) National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce to help strengthen the public health system in the United States.
A new preclinical model using CRISPR has given Weill Cornell Medicine researchers and their colleagues a deeper insight into how prostate cancer spreads or metastasizes.
A classic psychedelic was found to activate a cell type in the brain of mice and rats that silences other neighboring neurons, providing insight into how such drugs reduce anxiety.
Rural hospitals and hospitals that treat patients regardless of their ability to pay have been hampered by federal rules limiting their access to funding for capital projects, which has led to institutionalized racism in hospitals, researchers have found.
